These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

128 related items for PubMed ID: 4407083

  • 1. Seromucoid in serum in benign and malignant gynaecological disorders.
    Randle GH, Good W, Cumberbatch KN.
    J Obstet Gynaecol Br Commonw; 1974 Jun; 81(6):479-82. PubMed ID: 4407083
    [No Abstract] [Full Text] [Related]

  • 2. [A critical study on the differentiation of the acceleration of the erythrocyte sedimentation rate due to tumorous and inflammatory processes in diseases of the female genitalia].
    Schander K.
    Z Geburtshilfe Gynakol; 1969 Jun; 170(1):73-7. PubMed ID: 5794762
    [No Abstract] [Full Text] [Related]

  • 3. [Preliminary evaluation of the usefulness of determination of blood serum fucose and sialic acid level in women with genital tumors].
    Simm S, Markowska J, Tomaszkiewicz T, Herwichowska K.
    Ginekol Pol; 1979 Nov; 50(11):957-63. PubMed ID: 544355
    [No Abstract] [Full Text] [Related]

  • 4. Carcinoembryonic antigen in gynecologic patients. I. Correlation of plasma levels and tissue localization.
    Puri S, Mesa-Tejada R, Husami N, Bennett S, Richart RM, Fenogolio CM.
    Gynecol Oncol; 1977 Dec; 5(4):331-7. PubMed ID: 590854
    [No Abstract] [Full Text] [Related]

  • 5. [Biochemical findings in malignant neoplasms of the female genital organs].
    Koshkina SI, Makarov KS, Shiferson RG, Pchelkin EI, Zelentsovskaia GP.
    Vopr Onkol; 1967 Dec; 13(1):107. PubMed ID: 4176512
    [No Abstract] [Full Text] [Related]

  • 6. Serum protein-bound fucose in patients with gynecologic cancers.
    Barlow JJ, Dillard PH.
    Obstet Gynecol; 1972 May; 39(5):727-34. PubMed ID: 5023257
    [No Abstract] [Full Text] [Related]

  • 7. [Monitoring the course of malignant neoplasms of the genital organs in women by means of determination of blood serum level of fucose, sialic acid, CEA and AFP].
    Simm S, Markowska J, Tomaszkiewicz T, Herwichowska K, Breborowicz J.
    Ginekol Pol; 1979 Dec; 50(12):1029-36. PubMed ID: 94024
    [No Abstract] [Full Text] [Related]

  • 8. The circulating alpha subunit of human chorionic gonadotrophin in gynaecologic tumours.
    Rutanen EM.
    Int J Cancer; 1978 Oct 15; 22(4):413-21. PubMed ID: 700896
    [No Abstract] [Full Text] [Related]

  • 9. Serum copper alterations in genital cancer.
    O'Leary JA, Feldman M.
    Surg Forum; 1970 Oct 15; 21():411-2. PubMed ID: 5514783
    [No Abstract] [Full Text] [Related]

  • 10. [Behavior of the serum concentration of pregnancy associated alpha 2 glycoprotein (alpha 2-PAG) in gynecologic carcinomas (author's transl)].
    Tatra G.
    Strahlentherapie; 1981 Jul 15; 157(7):464-7. PubMed ID: 7268817
    [Abstract] [Full Text] [Related]

  • 11. Serum vitamins A and E and carotene in patients with gynecologic cancer.
    Heinonen PK, Kuoppala T, Koskinen T, Punnonen R.
    Arch Gynecol Obstet; 1987 Jul 15; 241(3):151-6. PubMed ID: 3435184
    [Abstract] [Full Text] [Related]

  • 12. Serum levels of T.P.A. (tissue polypeptide antigen) in gynecological malignancies.
    Restaino A, Fanizza G, Battarino O.
    Eur J Gynaecol Oncol; 1986 Jul 15; 7(3):183-5. PubMed ID: 3780759
    [Abstract] [Full Text] [Related]

  • 13. Cancer cells in the blood stream: review and personal findings with the fluorochrome method.
    Turchetti G, Palagi R, Gacci G.
    Gynaecologia; 1968 Jul 15; 165(3):253-60. PubMed ID: 4172110
    [No Abstract] [Full Text] [Related]

  • 14. [Plasma fibrinogen in female patients with genital cancer and its early stage].
    Lober R, Krantz S, Lober M.
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1985 Jul 15; 112(1):71-81. PubMed ID: 2581873
    [Abstract] [Full Text] [Related]

  • 15. Carcinoembryonic antigen in gynecologic patients. II. Immunohistological expression.
    Fenoglio CM, Crum CP, Pascal RR, Richart RM.
    Diagn Gynecol Obstet; 1981 Jul 15; 3(4):291-9. PubMed ID: 7338157
    [Abstract] [Full Text] [Related]

  • 16. Biochemical markers in gynaecological cancer.
    Farrell RJ.
    Ir Med J; 1980 Aug 15; 73(8):285-6. PubMed ID: 6161106
    [No Abstract] [Full Text] [Related]

  • 17. [Fibrinogen degradation products in gynecologic neoplasms].
    Tatra G, Breitenecker G, Karsai I.
    Fortschr Med; 1976 May 06; 94(13):752-4. PubMed ID: 955534
    [Abstract] [Full Text] [Related]

  • 18. [The serum copper/serum iron ratio in malignant tumors of the female genitalia].
    Maas DH, Hinckers HJ.
    Geburtshilfe Frauenheilkd; 1975 Aug 06; 35(8):619-26. PubMed ID: 1175904
    [Abstract] [Full Text] [Related]

  • 19. [Evaluation of serum ferritin in female genital neoplasms].
    Dong MY.
    Zhonghua Fu Chan Ke Za Zhi; 1991 Jan 06; 26(1):21-3, 61. PubMed ID: 1848498
    [Abstract] [Full Text] [Related]

  • 20. Acute reactive stage proteins in gynaecologic cancers.
    Paternoster D, Cartei G, Campagnutta E, Maggino T, Valente S, Ongaro G.
    Eur J Gynaecol Oncol; 1980 May 06; 1(2):94-8. PubMed ID: 6977448
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.